Product Program year 2025 Source: CMS Open Payments

Dragonfly Opstar

Device Vascular

PDI 05415067031129

Open in the dashboard

General payments

$1,465,546

6,573 payments

Research payments

$1,442,296

492 payments

Through program year 2025, $1,465,546 in general payments and $1,442,296 in research payments were reported against Dragonfly Opstar (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

9 rows
Year Kind Amount Payments
2025 General $261,400 1,616
2025 Research $159,446 52
2024 General $316,904 1,477
2024 Research $77,659 21
2023 General $329,449 1,460
2023 Research $544,467 106
2022 General $553,794 2,019
2022 Research $660,724 313
2021 General $4,000 1

Breakdown

Who paid General payments · program years 2021–2025
  1. Abbott Laboratories $1,465,546 6,573 payments
Top recipients General payments · program year 2025
  1. Ryan Madder Interventional Cardiology · Royal Oak, MI $15,996 6% · 10 payments
  2. Daniel Kiss Interventional Cardiology · Eatontown, NJ $11,998 5% · 11 payments
  3. Jeffrey Southard Cardiovascular Disease · Sacramento, CA $11,602 4% · 8 payments
  4. Aron Schwarcz Cardiovascular Disease · Englewood, NJ $10,428 4% · 25 payments
  5. Richard Sohn Interventional Cardiology · Portland, OR $9,937 4% · 9 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $142,475 57% · 358 practitioners
  2. Cardiovascular Disease Internal Medicine $90,032 36% · 193 practitioners
  3. Internal Medicine $5,544 2% · 54 practitioners
  4. Physician Assistant $1,952 <1% · 18 practitioners
  5. Hospitalist $1,893 <1% · 16 practitioners

The top 5 of 45 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $36,175 14% · 121 recipients
  2. New Jersey $34,045 13% · 46 recipients
  3. California $28,533 11% · 101 recipients
  4. New York $25,410 10% · 110 recipients
  5. Michigan $20,921 8% · 18 recipients

The top 5 of 47 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

6,573 general · 492 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record